PUBLISHER: Orion Market Research | PRODUCT CODE: 1159188
PUBLISHER: Orion Market Research | PRODUCT CODE: 1159188
Global Melanocyte Protein PMEL Market Size, Share and Trends Analysis Report by Type (AE-M vaccine, SCIB-1, VPI-121, and Others) by Application (Glioblastoma Multiforme, Melanoma and Metastatic Melanoma)Forecast Period (2022-2028)
The global melanocyte protein PMEL market is expected to rise at a considerable CAGR during the forecast period (2022-2028). The major factor driving the growth of the market includes the rising prevalence of melanoma across the globe. According to the American Cancer Society, in 2022, an estimated 99,780 new melanomas will be diagnosed globally. Out of which about 57,180 new cases will be diagnosed in men and 42,600 in women. PMEL mutations, on the other hand, have been observed to modify pheomelanic pigmentation in bovines, resulting in coat color dilution. Computer-assisted diagnosis techniques (dermoscopy and spectroscopy-based) for diagnosing skin cancer in adults: In this research, artificial intelligence is used in computer-assisted diagnostic (CAD) systems to analyze lesion data and make a skin cancer diagnosis. The conclusion of the research was that all CAD forms show great sensitivity in highly selected patient populations, and could be used as a backup for specialist diagnosis to enable to reduce the chance of missing melanomas. New clinical trials are now testing other immunotherapy drugs and combinations in SCC (Squamous Cell Carcinoma) and BCC(Basal Cell Carcinoma) can be future opportunities for the market.
The global melanocyte protein PMEL market is segmented based on type and application. Based on type, the market is segmented into AE-M vaccine, SCIB-1, VPI-121, and Others. Based on application the market is segmented into glioblastoma multiforme, melanoma, and metastatic melanoma. GBM(Glioblastoma Multiforme) is currently treated with chemotherapy using the medication temozolomide. During radiation therapy, the medicine is usually given every day, and then for six cycles afterward in the maintenance phase.
The global melanocyte protein PMEL market is further segmented based on geography Including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East and Africa, and Latin America).
The major companies serving the global melanocyte protein PMEL market include ImmunoCellular Therapeutics, Ltd., Vault Pharma Inc., Antigen Express, Inc., Immunomic Therapeutics, Inc., Scancell Holdings Plc, and others. To enhance their market share, industry participants are employing a number of critical techniques. For instance, Sarabhai Piramal Pharmaceuticals Ltd. made the chemotherapy drug FLUOROURACIL, 5-FUthat is used to treat cancer. It is applied to the skin to treat skin cancer and certain skin diseases that have the potential to become cancerous.
Research Methodology
The market study of the global melanocyte protein PMEL market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include:
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers: